Ultrasonography screening for hepatocellular carcinoma in Japanese patients with diabetes mellitus

Journal of Diabetes

Volumn 8, Issue 5, 2016, Pages 640-646

  Hiraoka, Atsushi ^a   Ochi, Marie ^a   Matsuda, Rie ^a   Aibiki, Toshihiko ^a   Okudaira, Tomonari ^a   Kawamura, Tomoe ^a   Yamago, Hiroka ^a   Nakahara, Hiromasa ^a   Suga, Yoshifumi ^a   Azemoto, Nobuaki ^a   Miyata, Hideki ^a   Miyamoto, Yasunao ^a   Ninomiya, Tomoyuki ^a   Hirooka, Masashi ^b   Abe, Masanori ^b   Matsuura, Bunzo ^b   Hiasa, Yoichi ^b   Michitaka, Kojiro ^a  

^a EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

diabetes mellitus; fatty liver; hepatocellular carcinoma; survey

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CHILD PUGH SCORE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ECHOGRAPHY; FEMALE; FIBROSIS 4 INDEX; HEPATOBILIARY PARAMETERS; HUMAN; JAPANESE (PEOPLE); LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84983084687     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12340     Document Type: Article

References (16)

1. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364: 829–41.
2. Noto H, Tsujimoto T, Noda M. Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians. J Diabetes Investig. 2012; 3: 24–33.
3. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004; 126: 460–8.
4. Noto H, Osame K, Sasazaki T, Noda M. Substantially increased risk of cancers in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complications. 2010; 24: 345–53.
5. The Committee of Japan Diabetes Society for the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus. J Japan Diab Soc. 1999; 42: 385–404 (in Japanese).
6. Yoneda M, Imajo K, Eguchi Y et al. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels. J Gastroenterol. 2013; 48: 1051–60.
7. Sobin L, Gospodarowicz M, Wittekind C (Eds). TNM Classification of Malignant Tumors, 7th edn. Hoboken, NJ, John Wiley & Sons, 2009.
8. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 5th edn. Kanehara, Tokyo; 2009 (in Japanese).
9. Ministry of Health Labour and Welfare. National Health and Nutrition Survey (in Japanese). 2012. Available at http://www.mhlw.go.jp/stf/houdou/0000032074.html, accessed 15 September 2015.
10. Chatterjee R, Mitra A. An overview of effective therapies and recent advances in biomarkers for chronic diseases and associated liver cancer. Int Immunopharmacol. 2015; 24: 335–45.
11. Kawamura Y, Arase IK et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol. 2012; 107: 253–61.
12. Okanoue T, Uemura A, Yasui K et al. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol. 2011; 26: 153–62.
13. Caldwell SH, Oelsner DH, Iezzoni JC et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease. Hepatology. 1999; 29: 664–9.
14. Michitaka K, Nishiguchi S, Aoyagi Y et al. Etiology of liver cirrhosis in Japan: A nationwide survey. J Gastroenterol. 2010; 45: 86–94.
15. Hashimoto E, Yatsuji S, Kaneda H et al. The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease. Hepatol Res. 2005; 33: 72–6.
16. Shah AG, Lydecker A, Murray K et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009; 7: 1104–12.